DEFIBROTIDE TREATMENT IN PAEDIATRIC PATIENTS WITH SEVERE/VERY SEVERE VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER HAEMATOPOIETIC CELL TRANSPLANTATION: DEFIFRANCE INTERIM RESULTS

• V. Gandemer,
• P. Schneider,
• A. Sirvent,
• R. Martin,
• V. Bouvatier,
• M. Labopin,
• M. Mohty

Affiliations

V. Gandemer

University Hospital of Rennes, Rennes, France

P. Schneider

University Hospital, Rouen, France

A. Sirvent

Hôpital Arnaud de Villeneuve, Montpellier, France

R. Martin

Jazz Pharmaceuticals, Oxford, United Kingdom

V. Bouvatier

Jazz Pharmaceuticals, Lyon, France

M. Labopin

Hôpital St Antoine, Sorbonne University, INSERM UMRs 938, Paris, France

M. Mohty

Hôpital St Antoine, Sorbonne University, INSERM UMRs 938, Paris, France